CLEC4G and breast carcinoma: For example, studies on gastric cancer have found that the expression of BTN3A3 can help predict the sensitivity of gastric cancer patients to the chemotherapeutic drug fluorouracil (22), while in breast cancer, BTN3A3 can enhance the stemness of breast cancer cells through interaction with LSECtin (23).